scholarly journals Status of serum magnesium in Egyptian children with type 1 diabetes and its correlation to glycemic control and lipid profile

Medicine ◽  
2016 ◽  
Vol 95 (47) ◽  
pp. e5166 ◽  
Author(s):  
Doaa Shahbah ◽  
Amr Abo El Naga ◽  
Tamer Hassan ◽  
Marwa Zakaria ◽  
Mohamed Beshir ◽  
...  
2021 ◽  
Vol 5 (Supplement_1) ◽  
pp. A457-A457
Author(s):  
Isabel Inácio ◽  
Teresa Azevedo ◽  
Sara Ferreira ◽  
Patrícia Rosinha ◽  
Márcia Alves ◽  
...  

Abstract Background: Many studies have shown an association between decreased serum magnesium (Mg) levels and poor glycemic control and dyslipidemia in patients with type 1 diabetes (T1DM). However, few studies have evaluated the association between reduced Mg levels and the diabetes complications in these patients and, in particular with diabetic retinopathy (DR), found divergent results. Aims: To evaluate the status of serum Mg levels in adults with T1DM and to assess the association between Mg levels and glycemic control, lipid profile and prevalence of DR. Methods: Retrospective study of adults with T1DM, with an ophthalmological evaluation and a serum Mg level determination. According to Mg levels, the patients were stratified into two groups: normomagnesemic (1.81–2.60 mg/dl) and hypomagnesemic (≤1.80 mg/dl) patients. Exclusion criteria were: patients on diuretics or proton-pump inhibitors, malabsorption or diarrhea, oral magnesium supplementation in recent past, pregnancy or sepsis. Results: Included 105 patients (56.2% male) with median age of 36.0 (interquartile range 16.0) years and median T1DM duration of 16.0 (12.0) years. Median HbA1c was 7.6 (1.5)% and median Mg levels was 1.96 (0.23) mg/dl. Hypomagnesemia (≤1.80 mg/dl) was detected in 20.0% (n=21) patients and 26.7% (n=28) had DR. Hypomagnesemic patients had higher HbA1c [8.2 (1.6) vs 7.5 (1.3)%, p=0.014]. There was no statistical difference in age, sex, T1DM duration or DR between the groups stratified by Mg levels. Mg levels was negatively and weakly correlated with systolic blood pressure (r=-0.200, p=0.041), HbA1c (r=-0.281, p=0.004) and BMI (r=-0.197, p=0.041). There was no correlation between Mg levels and total cholesterol, LDL-C, HDL-C or triglycerides. In multivariate logistic regression analysis, HbA1c was the only predictor of hypomagnesemia [OR=1.541 (1.027–2.312), p=0.037], after the adjustments for age, T1DM duration and BMI. There was no significant difference between patients with or without DR in relation to Mg levels [1.96 (0.28) vs 1.96 (0.19) mg/dL, p=0.986]. Also, there was no statistically significant association between Mg levels and the severity of DR or T1DM duration. In multivariate analysis, T1DM duration, male and estimated glomerular filtration rate >60mL/min/1.73m2 had independently significant association with DR after adjusting for age, glycemic control, hypertension, dyslipidemia, 25-hydroxyvitamin D and Mg levels [OR=1.194 (1.088–1.310), p=<0.001; OR=6.980 (1.654–29.450), p=0.008, and OR=0.780 (0.008–0.751), p=0.028, respectively]. Discussion: Hypomagnesemia is a common problem in adults with T1DM and it was correlated with glycemic control, although we did not find significant association between Mg levels and lipid profile or prevalence of DR. Future longitudinal studies may elucidate the causality between reduced Mg levels and the prevalence of diabetes complications.


Cureus ◽  
2022 ◽  
Author(s):  
Isabel Inácio ◽  
Teresa Azevedo ◽  
Ana Margarida Balsa ◽  
Sara Ferreira ◽  
Patrícia Rosinha ◽  
...  

2018 ◽  
Vol 22 (1) ◽  
pp. 89 ◽  
Author(s):  
Bedowra Zabeen ◽  
AnaMargarida Balsa ◽  
Nasreen Islam ◽  
Mukta Parveen ◽  
Jebun Nahar ◽  
...  

2021 ◽  
Vol 69 (1) ◽  
Author(s):  
Hend Soliman ◽  
Amany Ibrahim

Abstract Background Hyperglycemia and dyslipidemia are commonly found metabolic abnormalities in diabetic children and adolescents and both increase the risk of cardiovascular disease. This study aimed to assess the prevalence and the pattern of dyslipidemia in Egyptian children and adolescents with type 1 diabetes (T1DM) and determine its relation with the glycemic control. Results This retrospective study included 806 children and adolescents with T1DM; 358 (44.42%) males and 448 (55.58%) females. Their mean age was 11.71 ± 3.6 years. Clinical and laboratory data were recruited from patients’ files. Laboratory data include the most recent fasting lipid profile (triglycerides (TG), total cholesterol (TC), high-density lipoprotein (HDL) and low-density lipoprotein (LDL)), and the mean glycosylated hemoglobin (HbA1c) levels over the preceding year presented in percentage were calculated. Dyslipidemia in children and adolescents with T1DM represented 70.47% (568 patients). No statistically significant differences were detected between patients with and without dyslipidemia. As regards the pattern of dyslipidemia, high LDL and low HDL were the most frequent abnormalities in the study group; 62.16%, 60.21%, respectively. Patients with poor glycemic control (HbA1c > 7.5%) represent 73.45% and they were significantly older, with longer diabetes duration and higher TC, TG, and LDL compared to patients with good glycemic control. Significant positive correlations were found between HbA1c, TG, TC, and LDL with the age and diabetes duration. Conclusion We detected high prevalence of dyslipidemia in children and adolescents with T1DM. Therefore, dyslipidemia should be screened for in earlier ages in Egyptian children and adolescents suffering from T1DM. Programs directed to the prevention of dyslipidemia should be conducted, particularly for this group, in order to prevent/delay cardiovascular complications related to dyslipidemia. Also, parents should receive proper education targeting the prevention, control, and care of their diabetic children with dyslipidemia.


QJM ◽  
2021 ◽  
Vol 114 (Supplement_1) ◽  
Author(s):  
Mohamed R Halawa ◽  
Aliaa A. Abdo El-Sherbeeny ◽  
Salah H Elhalawany ◽  
Mohammed D Alesi

Abstract Background PrePubertal children with type 1 diabetes mellitus are shorter than their non- diabetic peers. we aimed to evaluate the role of HbA1c and IGFBP-3 in this phenomenon. Aim of the work: The aim of the study was to evaluate the effect of glycemic control on the growth and IGFBP-3, represented by height, weight, height and weight percentiles for age in a sample of prepubertal Egyptian children with T1DM. Patients and Methods This study was a cross sectional study conducted on 80 pre-pubertal Egyptian children, divided into 25 Males and 25 Females with T1DM and 30 age matched controls (15 Males and 15 Females), the participants were recruited from the Outpatient Clinic of the Pediatric Department of Ain Shams University Hospitals and the National Institute of Diabetes and Endocrinology in Cairo, Egypt during the period from July 2018 to August 2019. Anthropometric measures including height and weight were obtained and used to calculate the height and weight percentiles using the CDC calculators. HbA1c as well as IGFBP-3 levels were tested. Results The mean age (years) of the participants was (9.671±2.24) for male patients, (9.22 ± 2.19) for female patients and (8.39 ± 2.034) for controls. The height found to be lower in the children with T1DM when compared to the disease-free controls with median values of (129.287 ± 13.410) in male patients, (127.727 ±10.155) in female patients and (136.760 ± 13.431) in the controls. the height and weight percentiles (%) were found to be lower in the children with T1DM when compared to the disease-free controls, the height percentile with median values of 14.54 (IQR 27.95) in male patients, 17.93 (IQR 29.20) in female patients and 87.07 (IQR 20.48) in the controls. the weight percentile with median values of 40.68 (IQR 40.83) in male patients, 30.64(IQR 35.59) in female patients and 85.18 (IQR 20.17) in the controls. A negative correlation between HbA1c (%) and serum IGFBP-3 (ng/ml), height and height percentile were found with (0.014, 0.049 and 0.012) as well as a positive correlation between serum IGFBP-3 and height, height and weight percentiles (%), were found with (,0.004, 0.009 and 0.005 respectively). Serum IGFBP-3 levels were also found to be significantly lower in patients (P < 0.001) with a mean value of (198.6 ± 45.335) in male patients and (168.4 ± 44.317) in female patients and (285.333 ± 61.936) in the disease-free controls. Conclusion Serum IGFBP-3 levels (ng/ml) as well as growth are negatively affected in prepubertal children with T1DM in relation to the glycemic control.


Author(s):  
Mona Hafez ◽  
Mona Hassan ◽  
Noha Musa ◽  
Sahar Abdel Atty ◽  
Sally Abdel Azim

AbstractBackground:The association of low serum 25 hydroxy cholecalciferol (25OHD) levels with high glucose level and diminished insulin sensitivity suggests that vitamin D (VD) may modulate insulin metabolism. The aim of the study was to screen for vitamin D deficiency (VDD) in pediatric patients with type 1 diabetes (T1D) and study the effect of VD supplementation on their glycemic control and insulin requirements.Methods:A prospective cohort study including 50 patients with T1D. VD level was assessed initially and after 3 months of VD supplementation (in those with VDD). HbAResults:Fifty patients with T1D were included with mean diabetes duration of 4.11±2.34 years. VD level ranged from 0.2 to 33 ng/mL. VD status correlated significantly with daily insulin dose (p=0.030, r=0.306) and HbAConclusions:VD was highly prevalent in Egyptian T1D patients. VD supplementation improved glycemic control at 3 months after therapy with no reduction in insulin requirements.


Medicine ◽  
2017 ◽  
Vol 96 (11) ◽  
pp. e6352 ◽  
Author(s):  
Doaaa Shahbah ◽  
Tamer Hassan ◽  
Saeed Morsy ◽  
Hosam El Saadany ◽  
Manar Fathy ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document